In order to promote the development of China's low GI food industry, enhance the core competitiveness of China's low GI food industry and international competitiveness October 9-10, by the China Food Fermentation Industry Research Institute, Beijings Heartwarming Bio-technology Research Institute co-sponsored by the 2024 - Sixth China GI (Glycemic Index) International Conference “was grandly convened in Beijing. Our sister company Guangdong Qingyunshan Pharmaceutical Co., Ltd. attended the conference and was honored with the Technical Innovation Award of 2024-6th China GI International Conference.
Qingyunshan Pharmaceutical selects the best varieties of mulberry leaves, optimizes the process, and highly preserves and restores the original flavor and taste of mulberry leaves; for the safety risk indicators, the company has developed risk identification and control measures for each process linking from planting of medicinal herbs, harvesting and processing, storage and transportation, to extraction, filtration, concentration, and drying, which ensures the safety of the products.
On June 26, 2024, the group standard T/CNLIC 0145-2024 “General Technical Requirements for Low Glycemic Index (GI) Foods”, which was formulated under the auspices of the China National Institute of Food and Fermentation Research Ltd. by the China National Light Industry Council, was officially released. The introduction of this standard will provide a strong guarantee for standardizing the G1 food industry and improving consumer trust.
As one of the units for the development of this group standard, Qingyunshan Pharmaceuticals, with years of experience in the field of plant extracts, functional foods, health foods and drugs, actively promotes the development of this standard and gives professional support from the technical end, academic end and production end.
Qingyunshan Pharmaceutical has been deeply cultivating oriental herbs for more than 30 years, and has many years of experience in the cultivation of raw materials, technological research, development and production of health products, and ODM of functional foods.
As people pay more attention to health management and the incidence of metabolic diseases such as diabetes is increasing, the market demand for Gl products is also increasing. At the same time, the National Health Commission, together with other 15 departments, started to implement the “weight management year” activity implementation program, the international well-known periodical “The Lancet” released the global report on obese people, and the release of the 2023 China obesity map, the domestic and international weight management market continues to rise. Qingyunshan Pharmaceuticals has been actively laying out raw materials for health management, and after in-depth market research and technological demonstration, we have GlucoVest® dihydroberberberine ,Di-sugar® mulberry leaf, TF-Roberts® black tea, Pu'er Tea, Lotus Leaf, Hawthorn, and other popular blood glucose and blood lipid management raw materials.
As one of the units for the development of this group standard, Qingyunshan Pharmaceuticals, with years of experience in the field of plant extracts, functional foods, health foods and drugs, actively promotes the development of this standard and gives professional support from the technical end, academic end and production end.
Qingyunshan Pharmaceutical has been deeply cultivating oriental herbs for more than 30 years, and has many years of experience in the cultivation of raw materials, technological research, development and production of health products, and ODM of functional foods.
As people pay more attention to health management and the incidence of metabolic diseases such as diabetes is increasing, the market demand for Gl products is also increasing. At the same time, the National Health Commission, together with other 15 departments, started to implement the “weight management year” activity implementation program, the international well-known periodical “The Lancet” released the global report on obese people, and the release of the 2023 China obesity map, the domestic and international weight management market continues to rise. Qingyunshan Pharmaceuticals has been actively laying out raw materials for health management, and after in-depth market research and technological demonstration, we have GlucoVest® dihydroberberberine ,Di-sugar® mulberry leaf, TF-Roberts® black tea, Pu'er Tea, Lotus Leaf, Hawthorn, and other popular blood glucose and blood lipid management raw materials.
In the future, Qingyunshan Pharmaceutical will continue to implement the concept that “technological innovation is the core driving force of enterprise development”, give full play to its experience in the field of extraction and separation of Chinese herbal medicines, accelerate the technological upgrading of extracts, and promote the accelerated development of high-quality in the health industry. We will continue to pay close attention to the industry trends, take the consumer market as the leading role, optimize the raw material line and product line, and deepen the product system with the advantage of natural plant extracts.
